Radiotherapy is less often used by breast cancer patients with young children
12/30/2013
Radiotherapy (RT) after breast conserving surgery (BCS) has been shown to reduce the risk of breast cancer (BC) recurrence. However, although younger women tend to have more aggressive tumors and have higher risks of recurrence than older BC patients, they are less likely to receive RT after BCS, according to a study published December 24 in the Journal of the National Cancer Institute.
Surgery 'better than chemotherapy' for tongue cancer
12/30/2013
For the treatment of cancer, many would consider chemotherapy to be the best option. But for tongue cancer, new research suggests that surgery may be the most effective primary port of call. This is according to a study published in the journal JAMA Otolaryngology Head and Neck Surgery.
DNA clamp to grab cancer before it develops
12/30/2013
As part of an international research project, a team of researchers has developed a DNA clamp that can detect mutations at the DNA level with greater efficiency than methods currently in use. Their work could facilitate rapid screening of those diseases that have a genetic basis, such as cancer, and provide new tools for more advanced nanotechnology.
Saving fertility not priority at most cancer centers
12/29/2013
Infertility is consistently listed as one of the most distressing long-term side effects of cancer treatment for adolescents and young adults.
Low oxygen levels in tumors 'trigger spread of breast cancer'
12/29/2013
Researchers have discovered that low oxygen conditions can trigger the production of proteins that contribute to the spread of breast cancer cells. This is according to a study published in the Proceedings of the National Academy of Sciences.Biologists from Johns Hopkins University found that low oxygen conditions prompted increased production of proteins called RhoA and ROCK1.
Injectable gene therapy targets blood vessels in tumors
12/27/2013
By designing an injectable viral vector that targets blood vessels of tumors, researchers from Washington University School of Medicine in St. Louis, MO, have opened new avenues for gene therapy against cancer and other diseases that have abnormal blood vessels.
Pre-surgery chemo benefits more esophageal cancer patients
12/27/2013
A new study suggests having chemotherapy before surgery to remove a tumor may benefit more patients with esophageal cancer than previously thought.Tim Underwood, an esophageal surgeon researcher at the University of Southampton in the UK, and colleagues report their findings in the World Journal of Gastroenterology.
FDA approves Tretten to treat rare genetic clotting disorder
12/27/2013
The U.S. Food and Drug Administration has approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in the routine prevention of bleeding in adults and children who have a rare clotting disorder, known as congenital Factor XIII A-subunit deficiency. Congenital Factor XIII deficiency is an extremely rare genetic disorder.
Young killer cells protect against infectious mononucleosis
12/27/2013
More than 90 percent of all adults are carriers of the oncogenic Epstein-Barr Virus (EBV). Primary infection with this herpes virus as a young child is generally not linked to any symptoms, and usually offers life-long protection from its cancer-causing effect.
Study confirms target of potent chronic leukemia drug
12/27/2013
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) helps confirm that a molecule targeted by the experimental drug ibrutinib is critical for the development of chronic lymphocytic leukemia, the most common form of adult leukemia.